PLXS insider sale notice: 2,500 shares, acquired 2019, sale ~08/27/2025

Rhea-AI Filing Summary

Plexus Corp (PLXS) Form 144 - A holder has filed notice to sell 2,500 shares of Plexus common stock on or about 08/27/2025, with an aggregate market value of $344,275.00 based on the filing. The securities were acquired as performance shares on 02/12/2019. The filing states there are 26,986,726 shares outstanding and lists the proposed broker as Morgan Stanley Smith Barney LLC on NASDAQ. The notice also reports that Patrick Jermain sold 2,178 shares on 08/06/2025 for gross proceeds of $284,054.76. The filer certifies they are not aware of undisclosed material adverse information.

Positive

• Discloses planned sale of 2,500 shares with aggregate market value of $344,275.00
• Identifies acquisition as performance shares dated 02/12/2019, providing clear provenance
• Includes recent sale history (2,178 shares on 08/06/2025) improving transparency

Negative

• Insider sold 2,178 shares within the past month, which may be perceived negatively by some investors

Insights

Financial Analyst

Routine insider sale notice; modest size relative to outstanding shares, likely neutral to valuation.

The Form 144 documents a proposed sale of 2,500 Plexus shares valued at $344,275 and prior sales of 2,178 shares for $284,054.76. As these shares were issued as performance-based compensation in 2019, the transaction appears tied to executive compensation realization rather than a financing event. Relative to the 26,986,726 shares outstanding, the proposed sale is immaterial in dilution terms. The filing provides standard representations about lack of undisclosed material information, supporting disclosure compliance.

Compliance/Risk Analyst

Filing meets Rule 144 disclosure requirements; no compliance exceptions noted from the form itself.

The notice identifies the broker, the acquisition date and nature (performance shares), and prior recent sales by the same person, which are the key compliance elements for Rule 144 aggregation and reporting. The signature representation about absence of undisclosed material adverse information aligns with expected attestations. No statements in this filing indicate regulatory or disclosure risk beyond routine insider selling activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2500	344275.00	26986726	08/27/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2019	Performance Shares	Issuer			2500	02/12/2019	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PATRICK JERMAIN One Plexus Way Neenah WI 54957	Common	08/06/2025	2178	284054.76

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Plexus (PLXS) Form 144 disclose about the proposed sale?

The form notifies a proposed sale of 2,500 common shares on or about 08/27/2025 with an aggregate market value of $344,275.00.

Who is listed as having sold Plexus (PLXS) shares recently?

Patrick Jermain is listed as having sold 2,178 shares on 08/06/2025 for gross proceeds of $284,054.76.

When were the shares to be sold originally acquired?

The 2,500 shares were acquired as performance shares on 02/12/2019.

What broker is named for the proposed sale in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY.

How many Plexus shares are outstanding according to the filing?

The filing reports 26,986,726 shares outstanding.